Abstract:Cancer cachexia is defined as a multi‐factorial syndrome characterised by an ongoing loss of skeletal muscle mass and progressive functional impairment, estimated to affect 50–80% of patients and responsible for 20% of cancer deaths. Elevations in the morbidity and mortality rates of cachectic cancer patients has been linked to respiratory failure due to atrophy and dysfunction of the ventilatory muscles. Despite this, there is a distinct scarcity of research investigating the structural and functional condition of the respiratory musculature in cancer, with the majority of studies exclusively focussing on limb muscle. Treatment strategies are largely ineffective in mitigating the cachectic state. It is now widely accepted that an efficacious intervention will likely combine elements of pharmacology, nutrition, and exercise. However, of these approaches, exercise has received comparatively little attention. Therefore, it is unlikely to be implemented optimally, whether in isolation or combination. In consideration of these limitations, the current review describes the mechanistic basis of cancer cachexia, and subsequently explores the available respiratory‐ and exercise‐focussed literature within this context. The molecular basis of cachexia is thoroughly reviewed. The pivotal role of inflammatory mediators is described. Unravelling the mechanisms of exercise‐induced support of muscle via antioxidant and anti‐inflammatory effects in addition to promoting efficient energy metabolism via increased mitochondrial biogenesis, mitochondrial function, and muscle glucose uptake provide avenues for interventional studies. Currently available pre‐clinical mouse models including novel transgenic animals provide a platform for the development of multi‐modal therapeutic strategies to protect respiratory muscles in people with cancer. figure legend Cancer cachexia is characterised by profound loss of skeletal muscle mass. Exercise has the potential to counteract several factors that contribute to muscle wasting. Atrophy and dysfunction of the ventilatory muscles can result in respiratory compromise and ultimately failure. There is a scarcity of research investigating structure and function of the respiratory musculature in cancer. Pre‐clinical and clinical studies focussed on mechanisms of exercise‐induced support of muscle are required to drive the development of multi‐modal therapeutic strategies to protect respiratory muscles in people with cancer. This article is protected by copyright. All rights reserved

Possible synergism of physical exercise and ghrelin-agonists in patients with cachexia associated with chronic heart failure

Impact of Cancer Cachexia on Cardiac and Skeletal Muscle: Role of Exercise Training

Novel therapeutic options for cachexia and sarcopenia

Molecular mechanisms of cancer cachexia. Role of exercise training

Muscle wasting and cachexia in heart failure: mechanisms and therapies

Cancer cachexia prevention via physical exercise: molecular mechanisms

Exercise Training as Therapeutic Approach in Cancer Cachexia: A Review of Potential Anti-inflammatory Effect on Muscle Wasting

Physical exercise at the crossroad between muscle wasting and the immune system: implications for lung cancer cachexia

Controversies and Conundrums in Cardiac Cachexia: Key Questions About Wasting in Patients With HFrEF

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training

Exercise and nutrition interventions for renal cachexia

Inter-tissue communication in cancer cachexia

A multimodal approach to cancer-related cachexia: from theory to practice

Exercise and nutritional interventions on sarcopenia and frailty in heart failure: a narrative review of systematic reviews and meta‐analyses

Relationship between cachexia and short physical performance battery scores in patients with heart failure attending comprehensive outpatient cardiac rehabilitation

Impact of cancer cachexia on respiratory muscle function and the therapeutic potential of exercise

A Narrative Review of the Diagnosis and Treatment of Sarcopenia and Malnutrition in Patients with Heart Failure

Effect of Ghrelin on Energy Metabolism in Chronic Heart Failure

The Treatment of Ghrelin on Cardiac Cachexia in Congestive Heart Failure

Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies

Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia